AWA
GILD icon

Amplius Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Amplius Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$266K Buy
+2,109
New +$278K 0.02% 175
2022
Q1 		– Sell
-1,333
Closed -$96K – 451
2021
Q4 		$96K Buy
+1,333
New +$91.8K 0.01% 252

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Amplius Wealth Advisors's GILD Position: Q2 2026 in Review

Amplius Wealth Advisors opened a new position in Gilead Sciences (GILD) in Q2 2026: 2,109 shares worth $266K. The stake represents 0.02% of the portfolio and ranks #175 among its holdings. This is a return to the name: Amplius Wealth Advisors previously reported a position in GILD as recently as Q4 2021.

Amplius Wealth Advisors first reported a position in GILD in Q4 2021 and has held it in 2 quarters since. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Amplius Wealth Advisors held 2,109 shares of Gilead Sciences worth $266K as of Q2 2026.
  • Gilead Sciences was a new Amplius Wealth Advisors position in Q2 2026.
  • Gilead Sciences made up 0.02% of Amplius Wealth Advisors's portfolio in Q2 2026, its #175 holding.
  • Amplius Wealth Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 2 quarters since.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Amplius Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.